国产一区二区三区视频精品-国产一区二区三区视频在线观看-国产一区二区三区四区五区-国产一区二区三区四区五区精品-国产一区二区三区无码免费-国产一区二区三区在线

美國Oxygen Biotherapeutics   

Oxygen is essential to life. When that supply is shut off the results can range from minor to devastating. At Oxygen Biotherapeutics, our goal is to help the human body maintain a sufficient oxygen supply to stop disease and damage to tissues that occurs when the flow of oxygen is suddenly interrupted or diminished.
Currently, we are developing medical and cosmetic products designed to deliver oxygen to specific tissues in the body that are deprived of oxygen. Our most advanced product, Oxycyte PFC, is in Phase IIb clinical trials in Switzerland and Israel for the traumatic brain injury. Oxycyte PFC is an intravenously delivered perfluorocarbon-based drug that we believe has therapeutic benefits for acute ischemic conditions. The first cohort of the Phase IIb trail is complete and efforts are being made to resume the trials later this fiscal year with planned expansions in other countries.
In addition, we are developing a PFC-based topical cream that we believe has potential benefits for dermatologic indications and wounds. Studies in this area are underway in India.
On the cosmetic front, we have developed the DERMACYTE line of skin care products to address several common aging issues, such as fine lines, wrinkles, puffiness, skin tone, blemishes and more. DERMACYTE Oxygen Concentrate bathes your skin with rich oxygen, smoothing and moisturizing your complexion while helping to reduce the appearance of fine lines. DERMACYTE Oxygenating Eye Complex is a rich oxygen emollient infused with extracts and ingredients known to enhance hydration, increase suppleness, brighten skin tone and fight discoloration and puffiness. New skin care products are being developed to create a line of cosmetic products focused on skin care.